Yasumoto R, Kawano M, Tsujino T, Iwai Y, Hayashi S, Nishisaka N, Horii A, Kishimoto T
Department of Urology and Andrology, Osaka Municipal Juso Citizen's Hospital.
Hinyokika Kiyo. 1995 Oct;41(10):771-4.
The detection of various cytokines; interleukin-1 beta (IL-1 beta), interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha), was studied in patients with nonbacterial prostatitis (NBP), and the clinical efficacy of sparfloxacin was also reported. The seminal plasma of 11 normal men and 10 patients with NBP were examined for the cytokines. There was no IL-1 beta or IL-6 in the seminal plasma of normal men. TNF-alpha was detected in only one normal man. In the seminal plasma of the patients, IL-1 beta was detected in 2 out of 10, and IL-6 was also detected in 6. TNF-alpha was detected in 6 out of 10 patients with NBP. The rate of detection of IL-6 and TNF-alpha was significantly higher in the patients with NBP than in normal men. The average levels (range) of IL-1 beta, IL-6 and TNF-alpha were 28 pg/ml (27-29), 110 pg/ml (25-476) and 25 pg/ml (6-113), respectively. After treatment with sparfloxacin at a dose of 100 mg to 200 mg per day, their symptoms disappeared. The number of leukocytes in the seminal plasma decreased to the normal level and these cytokines were not detected. The favorable clinical effect was achieved in 13 of the 17 patients (76%). These findings suggested that the cytokines have an important role in the pathogenesis of prostatitis and that the level of the cytokines are useful indicators in patients with prostatitis, particularly with NBP.
对非细菌性前列腺炎(NBP)患者体内多种细胞因子,即白细胞介素-1β(IL-1β)、白细胞介素-6(IL-6)和肿瘤坏死因子-α(TNF-α)进行了检测,并报告了司帕沙星的临床疗效。对11名正常男性和10名NBP患者的精浆进行了细胞因子检测。正常男性精浆中未检测到IL-1β或IL-6。仅在一名正常男性中检测到TNF-α。在患者的精浆中,10例中有2例检测到IL-1β,6例检测到IL-6。10例NBP患者中有6例检测到TNF-α。NBP患者中IL-6和TNF-α的检测率显著高于正常男性。IL-1β、IL-6和TNF-α的平均水平(范围)分别为28 pg/ml(27 - 29)、110 pg/ml(25 - 476)和25 pg/ml(6 - 113)。每天给予100 mg至200 mg司帕沙星治疗后,患者症状消失。精浆中的白细胞数量降至正常水平,且未检测到这些细胞因子。17例患者中有13例(76%)取得了良好的临床效果。这些发现表明,细胞因子在前列腺炎的发病机制中起重要作用,且细胞因子水平是前列腺炎患者,尤其是NBP患者的有用指标。